Illumina to Shake Off the Shorts

Back in September, I believed the shares of Illumina (ILMN) would trade flat to down while investors waited for clarity regarding the size of the National Institutes of Health budget. As it turns out, the NIH budget was spared the worst, but stock was just about cut in half.

Earlier this week the shares rallied on the announcement that Illumina would begin selling a fantastic new genetic sequencing machine, the HiSeq 2500. Hoping to steal Illumina's thunder, Life Technologies (LIFE) rushed out a rival machine on the same day. Both companies claim their machines can map a genome in a single day. Both machines are expected to ship later this year....476 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.